HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eigo Otsuji Selected Research

Gastroenterostomy

2/2018Reconstruction method as an independent risk factor for postoperative bone mineral density loss in gastric cancer.
11/2017[A Case of Laparoscopic Remnant Gastrojejunal Bypass Surgery for Postoperative Peritoneal Recurrence of Gastric Cancer].
5/2016Reconstruction method as an independent risk factor for the postoperative decrease in hemoglobin in stage I gastric cancer.
2/2015Clinical outcomes and quality of life according to types of reconstruction following laparoscopy-assisted distal gastrectomy for gastric cancer.
7/2013Evaluation of postoperative nephrolithiasis and renal dysfunction in gastric cancer patients.
6/2012Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy.
3/2012Differences of the lymphatic distribution and surgical outcomes between remnant gastric cancers and primary proximal gastric cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eigo Otsuji Research Topics

Disease

207Neoplasms (Cancer)
07/2022 - 06/2002
154Stomach Neoplasms (Stomach Cancer)
11/2022 - 06/2002
45Esophageal Neoplasms (Esophageal Cancer)
08/2022 - 10/2005
40Neoplasm Metastasis (Metastasis)
03/2022 - 06/2002
39Esophageal Squamous Cell Carcinoma
12/2021 - 01/2011
31Colorectal Neoplasms (Colorectal Cancer)
07/2021 - 11/2002
29Carcinoma (Carcinomatosis)
01/2019 - 09/2004
25Hepatocellular Carcinoma (Hepatoma)
11/2021 - 04/2004
24Lymphatic Metastasis
01/2021 - 10/2005
15Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 11/2003
14Colonic Neoplasms (Colon Cancer)
01/2021 - 01/2003
14Rectal Neoplasms (Rectal Cancer)
01/2020 - 11/2002
9Adenocarcinoma
01/2019 - 09/2004
7Residual Neoplasm
10/2019 - 05/2010
7Hemorrhage
02/2017 - 07/2010
6Carcinogenesis
03/2022 - 11/2012
6Pancreatic Fistula (Pancreatic Fistulas)
12/2013 - 01/2008
5Infections
07/2022 - 11/2014
5Thrombosis (Thrombus)
05/2022 - 01/2015
5Breast Neoplasms (Breast Cancer)
01/2022 - 10/2011
5Body Weight (Weight, Body)
07/2020 - 05/2012
5Pathologic Constriction (Stenosis)
06/2020 - 11/2012
5Margins of Excision
01/2015 - 01/2011
4Abscess
07/2022 - 09/2012
4Pneumonia (Pneumonitis)
03/2022 - 08/2015
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2021 - 11/2011
4Necrosis
12/2018 - 11/2006
4Circulating Neoplastic Cells
08/2017 - 01/2007
4Anastomotic Leak
01/2016 - 03/2004
4Fibrosis (Cirrhosis)
08/2014 - 04/2004
3Diabetes Mellitus
11/2022 - 08/2014
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2021 - 11/2007
3Liver Diseases (Liver Disease)
01/2021 - 08/2016
3Anemia
01/2021 - 01/2014
3Surgical Wound Infection
01/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

38Biomarkers (Surrogate Marker)IBA
08/2022 - 07/2004
25AcidsIBA
06/2022 - 11/2009
22Proteins (Proteins, Gene)FDA Link
06/2022 - 07/2009
20MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
17Tumor Biomarkers (Tumor Markers)IBA
01/2018 - 07/2004
15protoporphyrin IXIBA
06/2022 - 11/2009
12Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 10/2004
11Cisplatin (Platino)FDA LinkGeneric
04/2022 - 12/2008
11DNA (Deoxyribonucleic Acid)IBA
04/2017 - 07/2004
9Cell-Free Nucleic AcidsIBA
02/2018 - 07/2007
9Indicators and Reagents (Reagents)IBA
11/2016 - 11/2010
8Monoclonal AntibodiesIBA
07/2013 - 01/2003
7Pharmaceutical PreparationsIBA
01/2019 - 06/2009
7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 10/2010
6C-Reactive ProteinIBA
08/2022 - 05/2013
6EnzymesIBA
06/2022 - 12/2010
6Biological ProductsIBA
03/2021 - 09/2004
6Carcinoembryonic AntigenIBA
05/2016 - 09/2004
5ChloridesIBA
10/2021 - 02/2008
5Messenger RNA (mRNA)IBA
05/2021 - 03/2007
51-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2020 - 03/2013
5SolutionsIBA
05/2017 - 10/2003
5Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2013 - 01/2009
5Interleukin-6 (Interleukin 6)IBA
06/2013 - 11/2009
5Cadherins (E-Cadherin)IBA
04/2007 - 09/2004
5CarbonIBA
10/2004 - 06/2002
4Glucose (Dextrose)FDA LinkGeneric
11/2022 - 10/2016
4Anti-Bacterial Agents (Antibiotics)IBA
07/2022 - 12/2015
4Therapeutic UsesIBA
03/2022 - 11/2006
4Fetal Proteins (Fetoprotein)IBA
11/2021 - 09/2013
4AnionsIBA
10/2021 - 09/2014
4Serum AlbuminIBA
01/2021 - 05/2015
4Photosensitizing Agents (Photosensitizers)IBA
01/2017 - 10/2013
4CarbohydratesIBA
01/2017 - 12/2010
4Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 06/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 11/2013
4AntigensIBA
05/2016 - 10/2004
4Docetaxel (Taxotere)FDA Link
05/2013 - 11/2009
3Amlodipine (Norvasc)FDA LinkGeneric
04/2022 - 01/2021
3Adenosine Triphosphatases (ATPase)IBA
11/2021 - 09/2014
3Chloride Channels (Chloride Channel)IBA
09/2021 - 09/2012
3Hemoglobins (Hemoglobin)IBA
03/2021 - 01/2014
3Angiogenesis InhibitorsIBA
01/2020 - 01/2009

Therapy/Procedure

97Gastrectomy
11/2022 - 06/2002
48Esophagectomy
08/2022 - 11/2010
46Drug Therapy (Chemotherapy)
07/2021 - 11/2002
37Therapeutics
08/2022 - 10/2003
37Lymph Node Excision (Lymph Node Dissection)
07/2022 - 11/2002
21Hepatectomy
10/2021 - 04/2004
17Chemoradiotherapy
01/2020 - 11/2009
13Adjuvant Chemotherapy
01/2021 - 10/2010
10Operative Surgical Procedures
01/2017 - 10/2009
9Neoadjuvant Therapy
10/2019 - 11/2012
8Conservative Treatment
07/2022 - 01/2008
7Operative Time
04/2020 - 03/2004
7Pancreaticoduodenectomy
12/2018 - 01/2008
7Gastroenterostomy
02/2018 - 03/2012
7Pancreatectomy
11/2016 - 07/2011
6Photochemotherapy (Photodynamic Therapy)
10/2020 - 03/2013
5Stents
07/2021 - 11/2012
5Laparotomy
01/2021 - 09/2009
5Colectomy
08/2015 - 09/2012
4Minimally Invasive Surgical Procedures
09/2019 - 11/2010
4Self Expandable Metallic Stents
01/2018 - 10/2005
4Radiofrequency Ablation
11/2017 - 10/2005